Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evoke Pharma Current Ratio 2012-2024 | EVOK

Evoke Pharma current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Evoke Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $0.01B $0.01B 1.28
2024-03-31 $0.01B $0.01B 1.39
2023-12-31 $0.01B $0.01B 0.71
2023-09-30 $0.01B $0.00B 3.50
2023-06-30 $0.01B $0.00B 4.29
2023-03-31 $0.01B $0.00B 5.93
2022-12-31 $0.01B $0.00B 7.09
2022-09-30 $0.01B $0.00B 7.06
2022-06-30 $0.01B $0.00B 10.65
2022-03-31 $0.01B $0.00B 6.65
2021-12-31 $0.01B $0.00B 7.51
2021-09-30 $0.01B $0.00B 8.34
2021-06-30 $0.02B $0.01B 2.80
2021-03-31 $0.02B $0.01B 3.07
2020-12-31 $0.01B $0.01B 1.23
2020-09-30 $0.01B $0.01B 1.01
2020-06-30 $0.01B $0.01B 1.23
2020-03-31 $0.01B $0.00B 2.64
2019-12-31 $0.01B $0.00B 3.10
2019-09-30 $0.01B $0.00B 3.39
2019-06-30 $0.01B $0.00B 5.88
2019-03-31 $0.00B $0.00B 3.31
2018-12-31 $0.01B $0.00B 3.46
2018-09-30 $0.01B $0.00B 4.35
2018-06-30 $0.01B $0.00B 5.23
2018-03-31 $0.01B $0.00B 4.67
2017-12-31 $0.01B $0.00B 3.82
2017-09-30 $0.01B $0.00B 4.06
2017-06-30 $0.01B $0.00B 7.00
2017-03-31 $0.02B $0.00B 13.05
2016-12-31 $0.01B $0.00B 6.58
2016-09-30 $0.01B $0.00B 10.69
2016-06-30 $0.01B $0.01B 0.75
2016-03-31 $0.01B $0.00B 2.82
2015-12-31 $0.01B $0.00B 5.19
2015-09-30 $0.01B $0.00B 5.82
2015-06-30 $0.01B $0.00B 3.32
2015-03-31 $0.01B $0.00B 5.03
2014-12-31 $0.02B $0.00B 8.24
2014-09-30 $0.01B $0.00B 7.90
2014-06-30 $0.02B $0.00B 9.22
2014-03-31 $0.02B $0.00B 7.48
2013-12-31 $0.02B $0.00B 10.69
2013-09-30 $0.02B $0.00B 9.00
2013-06-30 $0.00B $0.00B 0.61
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B $0.00B 2.73
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Teligent (TLGT) United States $0.000B 0.00